Certified Advisory Corp Vertex Pharmaceuticals Inc Transaction History

Certified Advisory Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $16,874 - $19,899	-90 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$207.02 - $241.31 $5,796 - $6,756	-28 Reduced 23.73%	90 $19,000
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $13,797 - $15,528	83 Added 237.14%	118 $20,000
Q4 2017 Feb 22, 2018	BUY	$137.28 - $155.55 $4,804 - $5,444	35	35 $5,000

1,708

220M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $113B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Certified Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Certified Advisory Corp with notifications on news.